Loading data...
Loading data...
Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | ABCL AbCellera Biologics Inc. - Common | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $12.63 -0.8% | $15.06 -2.0% |
| StockIQ Score | 57C Moderate Risk: Medium | 36F Weak Risk: Medium |
| Technical | 79B+ | 13F |
| Fundamental | 30F | 35F |
| Growth | 70B | 50C- |
| Fair Value | 38F | 38F |
| News | 80A- | 50C- |
| Quality | 42D | 50C- |
| Risk | 48D+ | 48D+ |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
AbCellera (ABCL) outperforms Ascentage (AAPG) in most categories. ABCL has a stronger investor score (54 vs. 37) and a higher overall rating (MODERATE vs. WEAK), along with better technical (69 vs. 18) and growth scores (70 vs. 50). Both share the same valuation score of 38, but ABCL’s fundamental score (30) is slightly higher than AAPG’s (35). ABCL shows more balanced strength across metrics.